| Alex Andrew Henderson, | |
|
1001 E Primrose St, Springfield, MO 65807-5155 | |
| (417) 875-3000 | |
| Not Available |
| Full Name | Alex Andrew Henderson |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 9 Years |
| Location | 1001 E Primrose St, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336521764 | NPI | - | NPPES |
| 200030761 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2015017261 (Missouri) | Secondary |
| 208800000X | Urology | 2020015781 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Centers | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lester E Cox Medical Centers | 8628092897 | 219 |
News Archive
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Authorities in Canada are now investigating a second suspected outbreak of bird flu in backyard poultry on Prince Edward Island.
Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining this week.
The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers. Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically removed after genetic testing for such cancers.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
› Verified 6 days ago
| Entity Name | Freeman-oak Hill Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679517023 PECOS PAC ID: 8325942253 Enrollment ID: O20040218000570 |
News Archive
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Authorities in Canada are now investigating a second suspected outbreak of bird flu in backyard poultry on Prince Edward Island.
Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining this week.
The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers. Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically removed after genetic testing for such cancers.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
› Verified 6 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760405864 PECOS PAC ID: 8628092897 Enrollment ID: O20060116000342 |
News Archive
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Authorities in Canada are now investigating a second suspected outbreak of bird flu in backyard poultry on Prince Edward Island.
Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining this week.
The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers. Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically removed after genetic testing for such cancers.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
› Verified 6 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174952212 PECOS PAC ID: 1658509864 Enrollment ID: O20140115001602 |
News Archive
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Authorities in Canada are now investigating a second suspected outbreak of bird flu in backyard poultry on Prince Edward Island.
Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining this week.
The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers. Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically removed after genetic testing for such cancers.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alex Andrew Henderson, Po Box 9007, Springfield, MO 65808-9007 Ph: (417) 875-3000 | Alex Andrew Henderson, 1001 E Primrose St, Springfield, MO 65807-5155 Ph: (417) 875-3000 |
News Archive
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Authorities in Canada are now investigating a second suspected outbreak of bird flu in backyard poultry on Prince Edward Island.
Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining this week.
The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers. Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically removed after genetic testing for such cancers.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
› Verified 6 days ago
Jennifer A Malossi, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1001 E Primrose St, Springfield, MO 65807 Phone: 417-875-3381 Fax: 417-875-3690 | |
Robert Clayton Scanlon Ii, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 1001 E Primrose St, Springfield, MO 65807 Phone: 417-875-3000 | |
Dr. Eric P. Guilliams, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1965 S Fremont Ave, Suite 370, Springfield, MO 65804 Phone: 417-882-0300 Fax: 417-882-9645 | |
Dr. Barry S Farber, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3850 S National Ave, Suite 320, Springfield, MO 65807 Phone: 417-269-6944 Fax: 417-269-6947 | |
Dr. Mark J. Walterskirchen, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1965 S Fremont Ave, Suite 370, Springfield, MO 65804 Phone: 417-820-0300 Fax: 417-882-9645 | |
Tyrun Keith Richardson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1965 S Fremont Ave, Ste 370, Springfield, MO 65804 Phone: 417-820-0300 | |
Howard W Follis, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1001 E Primrose St, Springfield, MO 65807 Phone: 417-875-3000 Fax: 417-875-3690 |